• Title of article

    Increased Rate of Stent Thrombosis and Target Lesion Revascularization After Filter Protection in Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: 15-Month Follow-Up of the DEDICATION (Drug Elution and Distal Prot

  • Author/Authors

    Anne Kaltoft، نويسنده , , Anne and Kelbوk، نويسنده , , Henning and Klّvgaard، نويسنده , , Lene and Terkelsen، نويسنده , , Christian Juhl and Clemmensen، نويسنده , , Peter and Helqvist، نويسنده , , Steffen and Lassen، نويسنده , , Jens Flensted and Thuesen، نويسنده , , Leif، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2010
  • Pages
    5
  • From page
    867
  • To page
    871
  • Abstract
    Objectives rpose of this study was to evaluate the long-term effects of distal protection during percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). ound e of distal filter protection during primary PCI increases procedure complexity and may influence lesion treatment and stent implantation. s EMI patients were assigned to distal protection (DP) (n = 312) or conventional treatment (CT) (n = 314). Clinical follow-up was performed after 1, 6, and 15 months, and angiographic follow-up after 8 months. All target lesion revascularizations (TLRs) were clinically driven. We report the pre-specified end points of stent thrombosis according to the criteria of the Academic Research Consortium, TLR, and reinfarction after 15 months. s tal number of stent thrombosis was 11 in the DP group and 4 in the CT group (p = 0.06). The rate of definite stent thrombosis was significantly increased in the DP group as compared with the CT group, with 9 cases versus 1 (p = 0.01). Clinically driven TLRs (31 patients vs. 18 patients, p = 0.05) and clinically driven target vessel revascularizations (37 patients vs. 22 patients, p = 0.04) were more frequent in the DP group. sions mary PCI for STEMI, the routine use of DP increased the incidence of stent thrombosis and clinically driven target lesion/vessel revascularization during 15 months of follow-up. (Drug Elution and Distal Protection in ST Elevation Myocardial Infarction Trial [DEDICATION]; NCT00192868)
  • Keywords
    primary PCI , distal protection , Stent thrombosis
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Serial Year
    2010
  • Journal title
    JACC (Journal of the American College of Cardiology)
  • Record number

    1746905